- Home
- FONR vs TARA Comparison
FONR vs TARA Comparison
Compare FONR & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- TARA
- Stock Information
- Founded
- FONR 1978
- TARA N/A
- Country
- FONR United States
- TARA United States
- Employees
- FONR N/A
- TARA N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FONR Health Care
- TARA Health Care
- Exchange
- FONR Nasdaq
- TARA Nasdaq
- Market Cap
- FONR 100.6M
- TARA 118.1M
- IPO Year
- FONR 1987
- TARA N/A
- Fundamental
- Price
- FONR $15.98
- TARA $3.12
- Analyst Decision
- FONR
- TARA Strong Buy
- Analyst Count
- FONR 0
- TARA 6
- Target Price
- FONR N/A
- TARA $19.80
- AVG Volume (30 Days)
- FONR 13.8K
- TARA 166.2K
- Earning Date
- FONR 09-26-2025
- TARA 08-11-2025
- Dividend Yield
- FONR N/A
- TARA N/A
- EPS Growth
- FONR N/A
- TARA N/A
- EPS
- FONR 1.28
- TARA N/A
- Revenue
- FONR $103,018,089.00
- TARA N/A
- Revenue This Year
- FONR N/A
- TARA N/A
- Revenue Next Year
- FONR N/A
- TARA N/A
- P/E Ratio
- FONR $12.52
- TARA N/A
- Revenue Growth
- FONR 0.29
- TARA N/A
- 52 Week Low
- FONR $12.00
- TARA $1.60
- 52 Week High
- FONR $17.98
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- FONR 64.17
- TARA 49.23
- Support Level
- FONR $15.07
- TARA $3.04
- Resistance Level
- FONR $15.22
- TARA $3.32
- Average True Range (ATR)
- FONR 0.19
- TARA 0.17
- MACD
- FONR 0.08
- TARA 0.00
- Stochastic Oscillator
- FONR 100.00
- TARA 41.67
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).